UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

The potential health effects of dietary phytoestrogens

British journal of pharmacology, 2017-06, Vol.174 (11), p.1263-1280

2017

Link zum Volltext

Verfügbarkeit prüfen

Studying the metabolic functionality of the intestinal microbiota in vitro

Toxicology letters, 2017-10, Vol.280, p.S12-S12

Beekmann, Karsten

2017

Link zum Volltext

Verfügbarkeit prüfen

An in vitromodel to quantify interspecies differences in kinetics for intestinal microbial bioactivation and detoxification of zearalenone

Toxicology reports, 2020-01, Vol.7, p.938-946

2020

Link zum Volltext

Verfügbarkeit prüfen

Determination of in vitro immunotoxic potencies of a series of perfluoralkylsubstances (PFASs) in human Namalwa B lymphocyte and human Jurkat T lymphocyte cells

Frontiers in toxicology, 2024-03, Vol.6, p.1347965-1347965

2024

Link zum Volltext

Verfügbarkeit prüfen

A state-of-the-art overview of the effect of metabolic conjugation on the biological activity of flavonoids

Food & function, 2012, Vol.3 (1), p.18-118

2012

Link zum Volltext

Verfügbarkeit prüfen

The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ)

Food & function, 2015-04, Vol.6 (4), p.198-117

2015

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic-Induced Changes in Microbiome-Related Metabolites and Bile Acids in Rat Plasma

Metabolites, 2020-06, Vol.10 (6), p.242

2020

Link zum Volltext

Verfügbarkeit prüfen

Physiologically based kinetic (PBK) modeling as a new approach methodology (NAM) for predicting systemic levels of gut microbial metabolites

Toxicology letters, 2024-05, Vol.396, p.94-102

2024

Link zum Volltext

Verfügbarkeit prüfen

Use of Physiologically Based Kinetic Modeling-Based Reverse Dosimetry to Predict in Vivo Toxicity from in Vitro Data

Chemical research in toxicology, 2017-01, Vol.30 (1), p.114-125

2017

Link zum Volltext

Verfügbarkeit prüfen

Physiologically‐Based Pharmacokinetic Modeling of the Postbiotic Supplement Urolithin A Predicts its Bioavailability Is Orders of Magnitude Lower than Concentrations that Induce Toxicity, but also Neuroprotective Effects

Molecular nutrition & food research, 2023-08, Vol.67 (15), p.e2300009-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Interaction between food-borne mycotoxins and gut microbiota: A review

Food control, 2021-08, Vol.126, p.107998, Article 107998

2021

Link zum Volltext

Verfügbarkeit prüfen

Differences in kinetics and dynamics of endogenous versus exogenous advanced glycation end products (AGEs) and their precursors

Food and chemical toxicology, 2022-06, Vol.164, p.112987-112987, Article 112987

2022

Link zum Volltext

Verfügbarkeit prüfen

Interindividual Differences in Human Intestinal Microbial Conversion of (−)-Epicatechin to Bioactive Phenolic Compounds

Journal of agricultural and food chemistry, 2020-12, Vol.68 (48), p.14168-14181

2020

Link zum Volltext

Verfügbarkeit prüfen

Inter- and Intraindividual Differences in the Capacity of the Human Intestinal Microbiome in Fecal Slurries to Metabolize Fructoselysine and Carboxymethyllysine

Journal of agricultural and food chemistry, 2022-09, Vol.70 (37), p.11759-11768

2022

Link zum Volltext

Verfügbarkeit prüfen

Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S‐Equol and Its Consequences for ERα Activation

Molecular nutrition & food research, 2020-03, Vol.64 (6), p.e1900912-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Front Cover: Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S‐Equol and Its Consequences for ERα Activation

Molecular nutrition & food research, 2020-03, Vol.64 (6), p.n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Inside Front Cover: Species Differences in in vitro and Estimated in vivo Kinetics for Intestinal Microbiota Mediated Metabolism of Acetyl‐deoxynivalenols

Molecular nutrition & food research, 2021-05, Vol.65 (9), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Differences in gut microbial fructoselysine degradation activity between breast-fed and formula-fed infants

FEMS microbiology ecology, 2022-12, Vol.99 (1)

2022

Link zum Volltext

Verfügbarkeit prüfen

Species Differences in in vitro and Estimated in vivo Kinetics for Intestinal Microbiota Mediated Metabolism of Acetyl‐deoxynivalenols

Molecular nutrition & food research, 2021-05, Vol.65 (9), p.e2001085-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Interindividual Differences in Human In Vitro Intestinal Microbial Conversion of Green Tea (‐)‐Epigallocatechin‐3‐O‐Gallate and Consequences for Activation of Nrf2 Mediated Gene Expression

Molecular nutrition & food research, 2021-01, Vol.65 (2), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells

Archives of toxicology, 2023-02, Vol.97 (2), p.457-468

2023

Link zum Volltext

Verfügbarkeit prüfen

An in vitro model for microbial fructoselysine degradation shows substantial interindividual differences in metabolic capacities of human fecal slurries

Toxicology in vitro, 2021-04, Vol.72, p.105078, Article 105078

2021

Link zum Volltext

Verfügbarkeit prüfen

Combining In Vitro Data and Physiologically Based Kinetic Modeling Facilitates Reverse Dosimetry to Define In Vivo Dose–Response Curves for Bixin‐ and Crocetin‐Induced Activation of PPARγ in Humans

Molecular nutrition & food research, 2020-01, Vol.64 (2), p.e1900880-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Predictive performance of next generation human physiologically based kinetic (PBK) models based on in vitro and in silico input data

ALTEX, alternatives to animal experimentation, 2022-03, Vol.39 (2), p.221–234-221–234

2022

Link zum Volltext

Verfügbarkeit prüfen

Use of proteomics to detect sex-related differences in effects of toxicants: implications for using proteomics in toxicology

Critical reviews in toxicology, 2018-09, Vol.48 (8), p.666-681

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)
Dissertationen
(1)

Sprache

Englisch
(31)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The potential health effects of dietary phytoestrogens

Studying the metabolic functionality of the intestinal microbiota in vitro

An in vitromodel to quantify interspecies differences in kinetics for intestinal microbial bioactivation and detoxification of zearalenone

Determination of in vitro immunotoxic potencies of a series of perfluoralkylsubstances (PFASs) in human Namalwa B lymphocyte and human Jurkat T lymphocyte cells

A state-of-the-art overview of the effect of metabolic conjugation on the biological activity of flavonoids

The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ)

Antibiotic-Induced Changes in Microbiome-Related Metabolites and Bile Acids in Rat Plasma

Physiologically based kinetic (PBK) modeling as a new approach methodology (NAM) for predicting systemic levels of gut microbial metabolites

Use of Physiologically Based Kinetic Modeling-Based Reverse Dosimetry to Predict in Vivo Toxicity from in Vitro Data

Physiologically‐Based Pharmacokinetic Modeling of the Postbiotic Supplement Urolithin A Predicts its Bioavailability Is Orders of Magnitude Lower than Concentrations that Induce Toxicity, but also Neuroprotective Effects

Interaction between food-borne mycotoxins and gut microbiota: A review

Differences in kinetics and dynamics of endogenous versus exogenous advanced glycation end products (AGEs) and their precursors

Interindividual Differences in Human Intestinal Microbial Conversion of (−)-Epicatechin to Bioactive Phenolic Compounds

Inter- and Intraindividual Differences in the Capacity of the Human Intestinal Microbiome in Fecal Slurries to Metabolize Fructoselysine and Carboxymethyllysine

Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S‐Equol and Its Consequences for ERα Activation

Front Cover: Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S‐Equol and Its Consequences for ERα Activation

Inside Front Cover: Species Differences in in vitro and Estimated in vivo Kinetics for Intestinal Microbiota Mediated Metabolism of Acetyl‐deoxynivalenols

Differences in gut microbial fructoselysine degradation activity between breast-fed and formula-fed infants

Species Differences in in vitro and Estimated in vivo Kinetics for Intestinal Microbiota Mediated Metabolism of Acetyl‐deoxynivalenols

Interindividual Differences in Human In Vitro Intestinal Microbial Conversion of Green Tea (‐)‐Epigallocatechin‐3‐O‐Gallate and Consequences for Activation of Nrf2 Mediated Gene Expression

Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells

An in vitro model for microbial fructoselysine degradation shows substantial interindividual differences in metabolic capacities of human fecal slurries

Combining In Vitro Data and Physiologically Based Kinetic Modeling Facilitates Reverse Dosimetry to Define In Vivo Dose–Response Curves for Bixin‐ and Crocetin‐Induced Activation of PPARγ in Humans

Predictive performance of next generation human physiologically based kinetic (PBK) models based on in vitro and in silico input data

Use of proteomics to detect sex-related differences in effects of toxicants: implications for using proteomics in toxicology

Suchergebnisse filtern